- Glycemia according to the Use of Continuous Glucose Monitoring among Adults with Type 1 Diabetes Mellitus in Korea: A Real-World Study
-
Lee YB, Kim M, Kim JH
- KMID: 2542517
- Diabetes Metab J.
- 2023 May;47(3):405-414.
- doi: 10.4093/dmj.2022.0032
Background: We explored the association between continuous glucose monitoring (CGM) use and glycemia among adults with type 1 diabetes mellitus (T1DM) and determined the status of CGM metrics among adults... -
- CITED
-
- Close
- SHARE
-
- Close
- Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control
-
Yoo JH, Kim JH
- KMID: 2538928
- Diabetes Metab J.
- 2023 Jan;47(1):27-41.
- doi: 10.4093/dmj.2022.0271
Continuous glucose monitoring (CGM) technology has evolved over the past decade with the integration of various devices including insulin pumps, connected insulin pens (CIPs), automated insulin delivery (AID) systems, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Laser and Conventional Lancing Devices for Blood Glucose Measurement Conformance and Patient Satisfaction in Diabetes Mellitus
-
Kim JA, Park MJ, Song E, Roh E, Park SY, Lee DY, Kim J, Yu JH, Seo JA, Choi KM, Baik SH, Yoo HJ, Kim NH
- KMID: 2536151
- Diabetes Metab J.
- 2022 Nov;46(6):936-940.
- doi: 10.4093/dmj.2021.0293
Self-monitoring of capillary blood glucose is important for controlling diabetes. Recently, a laser lancing device (LMT-1000) that can collect capillary blood without skin puncture was developed. We enrolled 150 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Glucose Profiles Assessed by Intermittently Scanned Continuous Glucose Monitoring System during the Perioperative Period of Metabolic Surgery
-
Kim K, Choi SH, Jang HC, Park YS, Oh TJ
- KMID: 2533640
- Diabetes Metab J.
- 2022 Sep;46(5):713-721.
- doi: 10.4093/dmj.2021.0164
Background: Continuous glucose monitoring (CGM) has been widely used in the management of diabetes. However, the usefulness and detailed data during perioperative status were not well studied. In this study,... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-World Analysis of Therapeutic Outcome in Type 1 Diabetes Mellitus at a Tertiary Care Center
-
Kietaibl A, Riedl M, Bozkurt L
- KMID: 2525134
- Diabetes Metab J.
- 2022 Jan;46(1):149-153.
- doi: 10.4093/dmj.2020.0267
Insulin replacement in type 1 diabetes mellitus (T1DM) needs intensified treatment, which can either be performed by multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII). This retrospective analysis... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study)
-
Bae JC, Kwak SH, Kim HJ, Kim SY, Hwang YC, Suh S, Hyun BJ, Cha JE, Won JC, Kim JH
- KMID: 2525128
- Diabetes Metab J.
- 2022 Jan;46(1):81-92.
- doi: 10.4093/dmj.2021.0016
Background: To evaluate the effects of teneligliptin on glycosylated hemoglobin (HbA1c) levels, continuous glucose monitoring (CGM)-derived time in range, and glycemic variability in elderly type 2 diabetes mellitus patients. Methods: This... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial
-
Bae JH, Ahn CH, Yang YS, Moon SJ, Kwak SH, Jung HS, Park KS, Cho YM
- KMID: 2525127
- Diabetes Metab J.
- 2022 Jan;46(1):71-80.
- doi: 10.4093/dmj.2020.0274
Background: To compare the efficacy and safety of two insulin self-titration algorithms, Implementing New Strategies with Insulin Glargine for Hyperglycemia Treatment (INSIGHT) and EDITION, for insulin glargine 300 units/mL (Gla-300)... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
-
Moon SJ, Jung I, Park CY
- KMID: 2522722
- Diabetes Metab J.
- 2021 Nov;45(6):813-839.
- doi: 10.4093/dmj.2021.0177
Since Banting and Best isolated insulin in the 1920s, dramatic progress has been made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely injection to... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of a Predictive Model for Glycated Hemoglobin Values and Analysis of the Factors Affecting It
-
Park H, Lee DY, Park Sy, Min J, Shinn J, Lee DH, Kwon SH, Kim HS, Kim NH
- KMID: 2536937
- Cardiovasc Prev Pharmacother.
- 2021 Oct;3(4):106-114.
- doi: 10.36011/cpp.2021.3.e14
Background: Glycated hemoglobin (HbA1c), which reflects the patient's blood sugar level, can only be measured in a hospital setting. Therefore, we developed a model predicting HbA1c using personal information and... -
- CITED
-
- Close
- SHARE
-
- Close
- Transient Neonatal Diabetes Mellitus Managed with Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring
-
Kim MS, Kim SE, Lee NY, Kim SK, Kim SH, Cho WK, Cho KS, Jung MH, Suh BK, Ahn MB
- KMID: 2513358
- Neonatal Med.
- 2021 Feb;28(1):41-47.
- doi: 10.5385/nm.2021.28.1.41
Neonatal diabetes mellitus can be categorized as transient, permanent, or syndromic, and approximately half of the cases are transient. We present a case involving a term newborn who showed overt... -
- CITED
-
- Close
- SHARE
-
- Close
- Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020
-
Rhee EJ, Kim MK, Lee WY
- KMID: 2513287
- Endocrinol Metab.
- 2021 Feb;36(1):41-50.
- doi: 10.3803/EnM.2021.106
Over the last two decades, our understanding of diabetes and treatment strategies have evolved tremendously, from scientific, mechanistic, and human perspectives. The categories of anti-diabetic medications expanded from a few... -
- CITED
-
- Close
- SHARE
-
- Close
- The Present and Future of Continuous Glucose Monitoring
-
Jin SM
- KMID: 2511881
- J Korean Diabetes.
- 2020 Dec;21(4):179-183.
- doi: 10.4093/jkd.2020.21.4.179
The accuracy and convenience of real-time continuous glucose monitoring (CGM) devices have been substantially improved in the past decade, with an accuracy comparable to finger-stick glucose meters. In addition, new... -
- CITED
-
- Close
- SHARE
-
- Close
- Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
-
Yoo JH, Kim JH
- KMID: 2513046
- Diabetes Metab J.
- 2020 Dec;44(6):828-839.
- doi: 10.4093/dmj.2020.0257
Glycosylated hemoglobin (HbA1c) has been the sole surrogate marker for assessing diabetic complications. However, consistently reported limitations of HbA1c are that it lacks detailed information on short-term glycemic control and... -
- CITED
-
- Close
- SHARE
-
- Close
- Lessons from Use of Continuous Glucose Monitoring Systems in Digital Healthcare
-
Kim HS, Yoon KH
- KMID: 2508002
- Endocrinol Metab.
- 2020 Sep;35(3):541-548.
- doi: 10.3803/EnM.2020.675
We live in a digital world where a variety of wearable medical devices are available. These technologies enable us to measure our health in our daily lives. It is increasingly... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of continuous glucose monitoring among Korean children and adolescents with type 1 diabetes mellitus
-
Kim JH
- KMID: 2507555
- Ann Pediatr Endocrinol Metab.
- 2020 Sep;25(3):145-151.
- doi: 10.6065/apem.2040038.019
Type 1 diabetes mellitus (T1DM) requires life-long insulin therapy because of diminished insulin-secretion capability. Glycemic control and glucose monitoring are important to prevent T1DM complications. Continuous glucose monitoring (CGM) measures... -
- CITED
-
- Close
- SHARE
-
- Close
- Glucose-Lowering Effect of Home-Delivered Therapeutic Meals in Patients with Type 2 Diabetes
-
Choi JH, Min SH, Lim KH, Shin UJ, Kim MS
- KMID: 2506774
- J Korean Diabetes.
- 2020 Mar;21(1):46-54.
- doi: 10.4093/jkd.2020.21.1.46
Background: Medical nutrition therapy is a fundamental part of diabetes management; however, it is very difficult for patients to maintain the recommended diet programs. We investigated whether providing home-delivered therapeutic... -
- CITED
-
- Close
- SHARE
-
- Close
- Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications
-
Cappon G, Vettoretti M, Sparacino , Facchinetti A
- KMID: 2455662
- Diabetes Metab J.
- 2019 Aug;43(4):383-397.
- doi: 10.4093/dmj.2019.0121
By providing blood glucose (BG) concentration measurements in an almost continuous-time fashion for several consecutive days, wearable minimally-invasive continuous glucose monitoring (CGM) sensors are revolutionizing diabetes management, and are becoming... -
- CITED
-
- Close
- SHARE
-
- Close
- Frequency of Self-Monitoring of Blood Glucose during the School Day Is Associated with the Optimal Glycemic Control among Korean Adolescents with Type 1 Diabetes
-
Joo EY, Lee JE, Kang HS, Park SG, Hong YH, Shin YL, Sohn M
- KMID: 2449625
- Diabetes Metab J.
- 2018 Dec;42(6):480-487.
- doi: 10.4093/dmj.2018.0018
BACKGROUND: This study aimed to evaluate the relationship between the frequency of self-monitoring of blood glucose (SMBG) and glycosylated hemoglobin (HbA1c) levels among Korean adolescents with type 1 diabetes mellitus... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of the IMB Model and an Evidence-Based Diabetes Self-management Mobile Application
-
Jeon E, Park HA
- KMID: 2418181
- Healthc Inform Res.
- 2018 Apr;24(2):125-138.
- doi: 10.4258/hir.2018.24.2.125
OBJECTIVES: This study developed a diabetes self-management mobile application based on the information-motivation-behavioral skills (IMB) model, evidence extracted from clinical practice guidelines, and requirements identified through focus group interviews (FGIs)... -
- CITED
-
- Close
- SHARE
-
- Close
- Improvement of Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus under Insulin Treatment by Reimbursement for Self-Monitoring of Blood Glucose
-
Song YS, Koo BK, Kim SW, Yi KH, Shin K, Moon MK
- KMID: 2409184
- Diabetes Metab J.
- 2018 Feb;42(1):28-42.
- doi: 10.4093/dmj.2018.42.1.28
BACKGROUND: In Korea, the costs associated with self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes mellitus (T2DM) under insulin treatment have been reimbursed since November 2015. We... -
- CITED
-
- Close
- SHARE
-
- Close
